O’Melveny Represents Leading Medical Imaging AI Company Diagens Biotechnology in US$101 Million Hong Kong IPO
March 30, 2026
Transaction Marks the First IPO of a Medical Imaging AI Model
FOR IMMEDIATE RELEASE
HONG KONG—March 30, 2026—O’Melveny represented Hangzhou Diagens Biotechnology Co., Ltd. (“Diagens”, 2526.HK) in its initial public offering and listing on the Main Board of the Hong Kong Stock Exchange. The total offering size was approximately HK$790 million (approximately US$101 million). O’Melveny acted as Hong Kong and U.S. counsel to Diagens and drafted the prospectus. Huatai Financial Holdings (Hong Kong) Limited acted as the sole sponsor, and Futu Securities International (Hong Kong) Limited acted as another key underwriter on this listing.
This transaction is widely recognized as the “first IPO of a medical imaging AI model”. Diagens is a medical device company focused on the development of medical imaging products and services. In 2024, it held the largest market share in China’s chromosome karyotype analysis system market by revenue in 2024. Its self-developed medical imaging foundation model, iMedImage, features a parameter scale at the hundred-billion level and supports 19 medical imaging modalities, covering over 90% of clinical medical imaging scenarios. Diagens’ products have been deployed in over 400 healthcare centers and medical institutions, including China’s top hospitals.
The offering was met with strong market reception, with the public offering oversubscribed by more than 1073 times.
This is the firm’s 22nd Chapter 18A listing. O’Melveny has advised on over a quarter of all biotech company IPOs since the Chapter 18A of Hong Kong’s Main Board Listing Rules were adopted in 2018.
The O’Melveny team was led by partners Ke Zhu, Ke Geng and Vincent Wang. The core team members included associates Alfred Li and Jingwei Huang, legal manager Rachel Peng, legal consultants Ziyan Gao and Xenia Zeng, trainee solicitor Bianca Cheng, and legal consultant intern Willing Lin. Counsel Brian Ge, associate Yirong Du, legal consultant Zheng Li, and legal consultant intern Lifeng Tan also provided valuable support.
About O’Melveny
It’s more than what you do: it’s how you do it. Across sectors and borders, in board rooms and courtrooms, we measure our success by yours. And in our interactions, we commit to making your O’Melveny experience as satisfying as the outcomes we help you achieve. Our greatest accomplishment is ensuring that you never have to choose between premier lawyering and exceptional service. So, tell us. What do you want to achieve? Visit us at www.omm.com; learn more in our firm at-a-glance; and find us on LinkedIn, Facebook, Instagram, and YouTube.
Contact:
Brandon Jacobsen
O’Melveny & Myers LLP
+1 213 430 8024
bjacobsen@omm.com
Chris Schob
O’Melveny & Myers LLP
+86 21 2307 7000
cschob@omm.com
# # #